Get the Stockscreener App
0.00
100.00%
-2.67
After Hours:
2.36
2.36
+
Psychemedics Corp stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
See More
Previous Close:
$2.67
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$15.74M
Revenue:
$22.10M
Net Income/Loss:
$-4.15M
P/E Ratio:
0.00
EPS:
-0.72
Net Cash Flow:
$-1.64M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$13,450.00
Psychemedics Corp Stock (PMD) Company Profile
Name
Psychemedics Corp
Sector
Industry
Phone
978-206-8220
Address
125 NAGOG PARK, ACTON, MA
Compare PMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PMD
Psychemedics Corp
|
0.00 | 15.74M | 22.10M | -4.15M | -1.64M | -0.72 |
|
TMO
Thermo Fisher Scientific Inc
|
419.89 | 161.06B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
196.71 | 140.63B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
471.38 | 35.74B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
106.46 | 30.51B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
151.10 | 26.57B | 15.41B | 1.37B | 2.11B | 7.50 |
Psychemedics Corp Stock (PMD) Latest News
Is Your Drug Testing Program Missing Critical Context? Psychemedics' New Quartile System Changes Everything - StockTitan
Psychemedics Corp announces qarterly EPS of $0.30 - Reuters
Psychemedics (NASDAQ:PMD) Shares Cross Above 200-Day Moving Average – Here’s Why - Defense World
Psychemedics Corp sees $305,439 in stock purchases by major shareholders - Investing.com
Psychemedics sees significant stock acquisition by investment group By Investing.com - Investing.com Nigeria
Peter Kamin sells $753,663 in Psychemedics Corp stock By Investing.com - Investing.com South Africa
Peter Kamin sells $753,663 in Psychemedics Corp stock - Investing.com India
Psychemedics Corporation (PMD) Completes Stock Repurchase Agreement - Defense World
Psychemedics completes share transactions, funds reverse split - Investing.com
Psychemedics completes share transactions, funds reverse split By Investing.com - Investing.com Canada
Post-Thanksgiving Insider Buying Includes Warren Buffett Pick - 24/7 Wall St.
Psychemedics Corporation's (NASDAQ:PMD) Shares Climb 37% But Its Business Is Yet to Catch Up - Simply Wall St
Psychemedics corp director Peter Kamin purchases $3.31m in stock By Investing.com - Investing.com Nigeria
Psychemedics corp director Peter Kamin purchases $3.31m in stock - Investing.com
Psychemedics Corporation Announces Charles Doucot, to Leave as Executive Vice President, Effective September 15, 2023 - Marketscreener.com
Psychemedics Corporation Announces Board Changes - Marketscreener.com
Psychemedics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 - Marketscreener.com
Psychemedics: Q2 Earnings Snapshot - Marketscreener.com
Psychemedics Corporation Appoints William Norris as Controller of the Company, Effective as of January 1, 2023 - Marketscreener.com
Psychemedics Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021 - Marketscreener.com
Psychemedics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 - Marketscreener.com
Psychemedics Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022 - Marketscreener.com
Psychemedics Corporation Declares Cash Dividend for First Quarter Ended March 31, 2022, Payable on June 24, 2022 - Marketscreener.com
Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller - Marketscreener.com
Psychemedics Corporation Appoints Charles M. Doucot as Vice President, Sales and Marketing - Marketscreener.com
Psychemedics Corp. Promotes Sarah Ashby to VP and General Counsel - Marketscreener.com
Psychemedics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 - Marketscreener.com
Psychemedics Corporation Announces Relocation of its Corporate Headquarters to Dallas, Texas - Marketscreener.com
Psychemedics Corporation announced that it expects to receive $3.749998 million in funding from 3K Limited Partnership - Marketscreener.com
Psychemedics: Q3 Earnings Snapshot - Marketscreener.com
Psychemedics Corporation Announces Reverse and Forward Stock Split - Yahoo Finance
PMD (Psychemedics) Shares Outstanding (EOP) : 5.90 Mil (As of Sep. 2024) - GuruFocus.com
Psychemedics shareholders approve reverse and forward stock splits - Investing.com
Psychemedics Corporation Reminds Stockholders to Cast Their Votes for Upcoming Annual Meeting of Stockholders - Yahoo Finance
Psychemedics Third Quarter 2024 Earnings: US$0.091 loss per share (vs US$0.36 loss in 3Q 2023) - Yahoo Finance
Psychemedics Q3 Loss Narrows Despite 9% Revenue Drop; Shares Show Mixed Results | PMD Stock News - StockTitan
Psychemedics Corporation Reports Third Quarter 2024 Financial Results - Yahoo Finance
Drug Screening Market Analysis of The Key Players, Growth Status, Business Strategies and Scope with Outlook - The Globe and Mail
U.S. Employer and Workplace Drug Testing Market Report 2024, Featuring First Advantage, Labcorp, Dragerwerk, Quest Diagnostics, Cordant Health Solutions, HireRight, Omega Laboratories & Psychemedics - Yahoo Finance
Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing - Yahoo Finance
Psychemedics Corporation Launches New Ketamine Hair Testing Service - Yahoo Finance
Psychemedics Corporation’s Board of Directors Approves Plan to Terminate Registration of Its Common Stock - GlobeNewswire
After Moving HQ to Dallas, Psychemedics Releases Report on Drug Trends in the U.S. Workplace - Dallas Innovates
Drug Testing Laboratories May Be Sued For Negligence In South Carolina - The National Law Review
DFW gets first HQ relocation of 2024, as Massachusetts company announces move - WFAA
Massachusetts drug testing firm targeting fentanyl relocates corporate HQ to Dallas - Dallas News
Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen - GlobeNewswire
Drug Screening Market AnalysisUS, Germany, China, Japan, CanadaSize and Forecast 2024-2028 - Technavio
Veteran NYPD cop fired by Commissioner Sewell over drug test sues to get job back - New York Daily News
Peter H. Kamin Enters into Cooperation Agreement with Psychemedics Corporation - Marketscreener.com
Psychemedics Corp. Appoints Drew Reynolds to Its Board of Directors - citybiz
Psychemedics Corp Stock (PMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):